Riding the pepTIDE — The Daily Wire on Therapeutic Peptides

An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.

Topic Sections

  • Top Shots — The most significant peptide and longevity stories ranked by overall editorial score
  • Research Signals — High-credibility scientific findings from journals, preprints, and clinical sources
  • Healing & Recovery — Tissue repair, injury recovery, and gut healing peptides including BPC-157 and TB-500
  • Growth Hormone Wire — Growth hormone secretagogues, peptide stacks, and GH axis research including Ipamorelin, CJC-1295, and MK-677
  • Metabolic & GLP-1 — Metabolic health, insulin sensitivity, and GLP-1 receptor agonist research including semaglutide and tirzepatide
  • Cognitive / Nootropic — Peptides targeting brain function, memory, neuroprotection, and cognitive enhancement
  • Skin & Cosmetic — Skin repair, anti-aging, collagen synthesis, and cosmetic peptide research including GHK-Cu and matrixyl
  • Reddit Finds — Community-sourced discussions, self-experimentation reports, and protocol threads from peptide communities
  • Contrarian Takes — Alternative viewpoints, dissenting research, and perspectives that challenge mainstream peptide narratives
  • Skeptic's Corner — Hype debunking, low-evidence alerts, and critical analysis of overstated peptide claims

Browse by Filter

  • Newest — Latest peptide and longevity stories
  • Most Credible — Highest credibility-scored stories
  • Most Edgy — High-novelty, unconventional findings
  • Most Discussed — Trending community discussions
  • Most Actionable — Direct applicability to daily health protocols
  • Lowest Risk — Stories with strong evidence, low hype
  • Research Only — Peer-reviewed and preprint studies
  • Reddit Only — Community discussion and anecdote
  • GLP-1 / Metabolic — Semaglutide, tirzepatide, and metabolic peptides
  • Healing / Recovery — BPC-157, TB-500, and repair protocols

More

  • About Riding the pepTIDE
  • Health Disclaimer
  • Submit a Source
  • Contact

Ibutamoren and Erectile Issues: The Evidence Is Sparse and Mixed

A short version: a recent piece looked at whether MK-677 (also called ibutamoren) causes erectile dysfunction. The article reviewed existing reports and small studies and tried to sort signal from noise. It didn’t announce a definitive answer. Instead it collected what’s been said so far and highlighted gaps in the evidence. MK-677 is a research chemical that people often describe as a growth-hormone secretagogue (plainly: it stimulates your body to release growth hormone). It’s not an insulin-like drug or a diabetes medicine like Ozempic. People use it in the bodybuilding and aging communities because it can raise levels of growth hormone and a related protein called IGF-1. It is not an approved prescription drug for boosting muscle or treating aging; much of the use is experimental or off-label. What the evidence actually shows is mixed and limited. There are case reports and user anecdotes on forums claiming erectile problems after taking MK-677. A few small studies in humans have measured hormone changes—like increases in growth hormone and sometimes mild effects on other sex hormones—but they were not designed to prove that MK-677 causes erectile dysfunction. Animal studies and larger clinical trials for other endpoints exist, but they don’t provide clear evidence that MK-677 impairs sexual function in most people. In short: some individuals report problems, but controlled data demonstrating a causal link are lacking. Why this matters: sexual side effects are a major concern for anyone considering a new drug or supplement. If MK-677 does affect erections for some people, that would change the risk–benefit calculation for athletes, older adults, or anyone seeking muscle or anti-aging benefits. People who have experienced unexplained sexual side effects while taking MK-677 or similar products would definitely care. Clinicians and researchers also need clearer data to give good advice. Caveats and risks are important here. MK-677 is not FDA-approved for most uses people take it for; quality and dosing can vary in the unregulated market. Reported side effects in studies include increased appetite, fluid retention, and changes in blood sugar and insulin sensitivity—issues that could indirectly affect sexual health. Because the evidence about erectile dysfunction is mainly anecdotal and from small studies, we can’t say who is at risk or how common it is. Anyone with heart disease, diabetes, prostate issues, or hormonal disorders should be especially cautious. Talk to a doctor before using such compounds and don’t assume forums reflect reliable safety data. Bottom line: there are reports linking MK-677 to erectile problems, but the scientific record is small and inconclusive; more controlled research is needed before drawing firm conclusions.

Source: Portal CNJ

Read full story

Back to Riding the pepTIDE